Research Article: Cutaneous Adverse Events After COVID- Vaccination
Introduction:
The Coronavirus disease (COVID-) pandemic, declared by the WHO, began in March and the first COVID- vaccine, an mRNA vaccine (Pfizer), was approved by the US FDA for Emergency Use Authorization. Currently, nine COVID- vaccines are available on the emergency list of World Health Organization (WHO): mRNA (BNTb; Pfizer, mRNA-; Moderna), viral vectors (ChAdOx nCoV-; AstraZeneca, Ad.COV.S; Johnson & Johnson, Ad-nCoV-S; Convidecia), inactivated vaccines (CoronaVac; Sinovac, BBIBP-CorV; Sinopharm, BBV; Covaxin) and…
Read more